Introduction {#S0001}
============

Obesity is one of the most serious health threats all over the world \[[@CIT0001]\] and leads to chronic diseases such as cardiovascular disease (CVD), diabetes mellitus (DM), and dyslipidemia \[[@CIT0002], [@CIT0003]\]. The cut-off points of anthropometric indices such as body mass index (BMI) and waist circumference (WC) are usually obtained by epidemiological studies conducted on Caucasians, especially Europeans; therefore, they are not necessarily representative of the indices in other ethnicities \[[@CIT0004]\]. The values of these indices are varied in youth \[[@CIT0005]\] and adults \[[@CIT0006]--[@CIT0008]\] with respect to race; for instance, the cut-off points of WC in studies in Oman, Iraq and Korea were 80 cm, 97 cm and 90 cm respectively in men and 84.5 cm, 99 cm and 85 cm respectively in women \[[@CIT0006]--[@CIT0008]\]. These cut-off points can also be dissimilar between the rural and urban populations of one region \[[@CIT0009], [@CIT0010]\]. Obesity and its complications are more prevalent in the Middle East \[[@CIT0011]\]. The World Health Organization (WHO) has defined the normal range of BMI as 18.5 kg/m^2^ to 22 kg/m^2^ in the Asian population \[[@CIT0012]\]. Moreover, due to a lack of fresh data on the normal range of WC in the Middle East, the International Diabetes Federation (IDF) suggests that the normal range of Europeans, namely 94 cm in men and 80 cm in women, be applied for the definition of the normal WC in this region \[[@CIT0013]\].

Given the paucity of information on the normal range of WC and BMI in Iran and the Middle East, at least in the adult population, we used data from the First Non-Communicable Disease (NCD) risk factors surveillance in Iran in 2005 to estimate the cut-off points of WC and BMI for detecting DM, hypercholesterolemia (HC), and hypertension (HTN).

Material and methods {#S0002}
====================

The first national NCD risk factors surveillance was a cross-sectional study which was conducted in 2005, the detailed protocol of that is available elsewhere \[[@CIT0014]\].

The samples were selected via the multi-stage cluster sampling method according to the WHO stepwise approach to NCD risk factors \[[@CIT0015]\]. Each cluster contained 20 participants, half of each cluster being men.

In total, 89,440 participants aged between 15 and 64 years from the rural and non-institutionalized urban populations of 28 provinces of Iran were included. Our study was focused on 25 to 64-year-old individuals, so the sample size was reduced to 70,981.

A national committee was established to evaluate the protocols, guidelines, and tools for preventing any technical or ethical errors. The study was approved by the Ethics Committee of the Iranian Center for Disease Management and Control, and informed written and oral consent was obtained from the participants.

Height, weight, WC, and blood pressure were evaluated via physical examinations; fasting blood glucose (FBG) and cholesterol levels were assessed via laboratory tests. Data were gathered through a questionnaire based on the WHO\'s stepwise approach to NCD risk factors surveillance and filled in via face-to-face interviews by trained personnel. All the instruments were standardized before the examinations on a daily basis.

Height was measured using a portable inflexible bar while the participants were looking straight forward with their heels against the wall. Weight was measured with a daily calibrated analogue portable scale. During all the weight and height measurements, the individuals were in light clothing without shoes and socks. Waist circumference was measured using the standard constant tension tape, measuring the midaxillary line at the mid-point between the free head of the lower rib and the anterior superior iliac spine at the end of normal expiration \[[@CIT0013]\]. Body mass index was estimated by dividing weight in kilograms by the square of the height in meters \[[@CIT0011]\].

Blood pressure was measured with appropriate-sized cuffs from the right arm and in the sitting position after 5 min' rest. The first Korotkoff sound indicated systolic blood pressure, and the disappearance of the sound signified diastolic blood pressure. The mean blood pressure after two measurements with 5-minute intervals was recorded. If the difference between systolic blood pressure and/or diastolic blood pressure in the two measurements was more than 10 mm Hg, the third measurement was recorded. Abnormal blood pressure was defined as a history of antihypertensive drug use or systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm Hg \[[@CIT0016]\]. All the sphygmomanometers were calibrated daily by the Mercury Richter Sphygmomanometer.

Venous blood samples were obtained after 12 h' fasting and in the sitting position. Samples collected incorrectly or those obtained from non-fasting individuals were excluded.

Fasting blood glucose and cholesterol were assessed via enzymatic methods using the Pars Azmun (Pars Azmun Co., Tehran, Iran) Kit. The kits in all the laboratories bore the same serial and production permit numbers with the same expiration date. Fasting blood glucose was measured via the glucose oxidase/peroxidase-4 aminophenazone-phenol (GOD-PAP) method, and cholesterol was assessed via the cholesterol oxidase/p-aminophenazone (CHD-PAP) method. Individuals with physician-diagnosed DM, as well as those with a history of oral hypoglycemic agents or insulin or with FBG \> 126 mg/dl were categorized as diabetics \[[@CIT0017]\]. Blood cholesterol level ≥ 200 mg/dl \[[@CIT0018]\] or positive history of taking cholesterol-lowering agents was regarded as HC.

Statistical analysis {#S20003}
--------------------

The receiver operating characteristic (ROC) curves were employed to achieve the cut-off points of WC and BMI for detecting HTN, DM, and HC. The points with the maximum sum of sensitivity and specificity indicated the cut-off points. For analysis, SPSS software version 15 was applied.

Results {#S0004}
=======

This study recruited 70,981 men and women between 25 and 64 years of age from 28 provinces of Iran. The study population comprised 50.5% men and 49.5% women, and the male-to-female ratio in each age group was approximately similar. Individuals from urban and rural areas accounted for 46.6% and 35.4% of the study population, respectively.

The mean BMI in the men and women was 25.1 ±4.1 kg/m^2^ and 27.2 ±5.0 kg/m^2^, respectively. The mean WC was 88.7 ±12.3 cm in the men and 92.3 ±13.8 cm in the women. The frequency of DM, HTN, and HC was 6.7%, 31.1%, and 45.1% respectively in the men and 9.5%, 34.6%, and 53.1% respectively in the women. In total, the frequency of DM, HTN, and HC was 8.1%, 32.8%, and 49.3%, respectively. The cut-off point of WC for detecting HTN with 63% sensitivity (95% CI: 0.63-0.64) and 59% specificity (95% CI: 0.59-0.60) was 89.7 cm in the men, whereas the cut-off point with 63% sensitivity (95% CI: 0.62-0.63) and 60% specificity (95% CI: 0.60-0.61) was 93.9 cm in the women. The cut-off point of WC for detecting DM and HC was 89.4 cm and 88.2 cm respectively in the men and 96.2 cm and 90 cm respectively in the women. The cut-off points of BMI for detecting DM, HTN, and HC in the men and women are depicted in [Table I](#T0001){ref-type="table"}.

###### 

Cut-off points of waist circumference and body mass index for detecting diabetes, hypercholesterolemia, and hypertension in 25 to 64-year-old Iranians according to the First Non-Communicable Disease Survey in Iran in 2005

  Disease                Gender   Anthropometric indices   Cut-off point      Sensitivity (95% CI)   Specificity (95% CI)
  ---------------------- -------- ------------------------ ------------------ ---------------------- ----------------------
  Hypertension           Male     BMI                      25.7               0.55 (0.54-0.55)       0.64 (0.64-0.65)
  WC                     89.7     0.63 (0.63-0.64)         0.59 (0.59-0.60)                          
  Female                 BMI      26.9                     0.62 (0.62-0.62)   0.57 (0.56-0.57)       
  WC                     93.9     0.63 (0.62-0.63)         0.60 (0.60-0.61)                          
  Diabetes               Male     BMI                      24.8               0.69 (0.68-0.69)       0.50 (0.50-0.51)
  WC                     89.4     0.71 (0.70-0.71)         0.53 (0.53-0.54)                          
  Female                 BMI      26.3                     0.71 (0.71-0.71)   0.46 (0.46-0.47)       
  WC                     96.2     0.61 (0.61-0.62)         0.62 (0.62-0.63)                          
  Hypercholesterolemia   Male     BMI                      24.0               0.69 (0.69-0.70)       0.49 (0.49-0.50)
  WC                     88.2     0.62 (0.62-0.63)         0.57 (0.57-0.58)                          
  Female                 BMI      26.1                     0.64 (0.64-0.65)   0.51 (0.50-0.51)       
  WC                     90.0     0.66 (0.65-0.66)         0.53 (0.52-0.53)                          

BMI -- body mass index \[kg/m^2^\], WC -- waist circumference \[cm\]

All the cut-off points of WC and BMI in association with the above-mentioned complications were higher in the women than in the men. The cut-off points of BMI in both genders and the cut-off point of WC in the men for detecting HTN were higher than those for DM, and the cut-off points for detecting DM were higher than those for HC. On the other hand, in the women, the cut-off point for detecting DM was higher than that for HTN and the cut-off point for detecting HTN was higher than that for HC ([Table I](#T0001){ref-type="table"}).

Discussion {#S0005}
==========

In other studies the cut-off points of WC and BMI are different from ours ([Tables II](#T0002){ref-type="table"}-[III](#T0003){ref-type="table"}). For instance, the WHO has defined normal WC as 102 cm in men and 88 cm in women \[[@CIT0001]\] and normal BMI in Asians as 18.5 kg/m^2^ to 22 kg/m^2^ due to a higher prevalence of DM in lower BMI ranges in this region \[[@CIT0012]\]. However, the IDF has suggested that the normal ranges of Europeans, namely 94 cm in men and 80 cm in women, be applied for a definition of normal WC in the Middle East \[[@CIT0013]\]. According to a study in the capital of Iran (Tehran), normal WC in men and women was defined as 91.5 cm and 85.5 cm, respectively \[[@CIT0018]\]. This study was conducted in 2008 on 2,752 participants aged between 18 and 80 from 4 geographical regions of Tehran; the sensitivity and specificity of the cut-off points were compared with the ranges recommended by the IDF and the Adult Treatment Panel III (ATP III). The sensitivity of WC in men and women was 77% and 86%, respectively; and the specificity was 58% and 50%, respectively. The sensitivity of WC in men was higher than that suggested by the IDF and it was lower in women. Furthermore, specificity in men was lower than that suggested by the IDF but it was higher in women \[[@CIT0018]\]. In comparison with the ATP III, which defines normal WC as 102 cm in men and 88 cm in women \[[@CIT0019]\], in both genders sensitivity was higher and specificity was lower \[[@CIT0018]\]. In this study, the value of WC in women was lower than that in men, which was not consistent with our results. One possible explanation is the fact that women in Tehran work outside of their houses more than other Iranian women.

###### 

Cut-off points of waist circumference in different studies and their comparison with our results

  Study name \[reference\]                                                       Cut-off points of waist circumference \[cm\]   
  ------------------------------------------------------------------------------ ---------------------------------------------- ------
  Our study (for detecting hypertension)                                         89.7                                           93.9
  Our study (for detecting diabetes)                                             89.4                                           96.2
  Our study (for detecting hypercholesterolemia)                                 88.2                                           90
  Iran (for detecting metabolic syndrome) \[[@CIT0020]\]                         89                                             91
  Iran (for detecting cardiovascular disease) \[[@CIT0022]\]                     94.5                                           94.5
  Tehran (Iran) (for detecting metabolic syndrome risk factors) \[[@CIT0019]\]   91.5                                           85.5
  International Diabetes Federation (normal ranges) \[[@CIT0013]\]               94                                             80
  World Health Organization (normal ranges) \[[@CIT0001]\]                       102                                            88
  Adult Treatment Panel III (normal ranges) \[[@CIT0018], [@CIT0019]\]           102                                            88
  Korea (for detecting metabolic syndrome) \[[@CIT0024]\]                        83                                             76
  Korea (for detecting diabetes) \[[@CIT0024]\]                                  85                                             77
  Korea (for detecting ischemic heart disease) \[[@CIT0024]\]                    87                                             74
  Korea (for detecting hypertension) \[[@CIT0024]\]                              84                                             77
  Korea (for detecting central obesity) \[[@CIT0007]\]                           85                                             80
  Japan (for detecting central obesity) \[[@CIT0025]\]                           89.8                                           82.3
  China (for detecting metabolic syndrome) \[[@CIT0026]\]                        90                                             85
  China (for detecting central obesity) \[[@CIT0027]\]                           85                                             80
  Oman (for detecting cardiovascular disease risk factors) \[[@CIT0006]\]        80                                             84.5
  Iraq (for detecting metabolic syndrome) \[[@CIT0008]\]                         97                                             99
  disease and diabetes) \[[@CIT0023]\]                                           85                                             85
  Asian Indian (normal ranges) \[[@CIT0028]\]                                    85                                             80

In the NCD Risk Factors Surveillance, which was carried out in 2007 in Iran, 3,027 men and women from 30 provinces participated; the best cut-off point of WC for detecting the metabolic syndrome was 89 cm in men and 91 cm in women \[[@CIT0020]\]. The WC was higher in women and it was in line with our results. In Iranian culture, the number of women with a paid job outside of their houses is lower than that of men. Additionally, lack of physical activity is seen in 70% to 80% of the Iranian population and it is thus one of the general health problems \[[@CIT0021]\].

Hadaegh *et al*. conducted a study in Iran over a period of 7.6 years on 3,620 men and women over 40 years old with no history of CVD to determine the anthropometric values with respect to the incidence of CVD. The cut-off point of BMI according to the ROC curves and maximum sensitivity and specificity was 26.95 kg/m^2^ in men and 29.19 kg/m^2^ in women. The cut-off point of WC for detecting CVD according to maximum sensitivity and specificity in both genders was 94.5 cm \[[@CIT0022]\]. Whereas the said study was a longitudinal population-based study, ours was a cross-sectional one conducted on a huge sample (79,611 participants). The suggested value for the cut-off point of WC in Oman for detecting CVD risk factors defined by at least 2 of 3 risk factors (hyperglycemia, HTN, and dyslipidemia) was 80 cm in men and 84.5 cm in women \[[@CIT0006]\]. In Iraq, the cut-off point according to maximum sensitivity and specificity for detecting the metabolic syndrome was 97 cm in men and 99 cm in women. Moreover, the sensitivity and specificity of applying these values were 70% and 50% respectively in men and 70% and 45% respectively in women \[[@CIT0008]\]. In Tunisia, the cut-off point according to the ROC curves for diagnosing central obesity and for detecting CVD risk factors and DM in both genders was 85 cm. The WC value, which was 85 cm in men and 79 cm in women, had more than 90% sensitivity and more than 83% specificity for detecting individuals with BMI =≥ 25 kg/m^2^ \[[@CIT0023]\].

In Korea, men with 90 cm and women with 86.5 cm WC were in the 80^th^ percentile of WC, and the cut-off point for detecting central obesity was 85 cm in men and 80 cm in women \[[@CIT0007]\]. In another study in Korea, the cut-off point of WC according to maximum sensitivity and specificity for detecting ischemic myocardial diseases in men and women was 87 cm and 74 cm respectively and for detecting HTN, DM, and risk factors of the metabolic syndrome was 84 cm, 85 cm, and 83 cm in men and 77 cm, 77 cm, and 76 cm in women, respectively \[[@CIT0024]\]. In Japan, the best cut-off point by the ROC curves for detecting central obesity in men was higher than that in women (89.8 cm vs. 82.3 cm) \[[@CIT0025]\]. In China, this value according to the ROC curves for detecting the metabolic syndrome was 90 cm in men and 85 cm in women \[[@CIT0026]\]. In another study in China, the best cut-off point for detecting central obesity was 85 cm in men and 80 cm in women \[[@CIT0027]\]. The normal WC value in the Asian Indian population was 85 cm in men and 80 cm in women \[[@CIT0028]\].

In our study, WC was higher in the women than in the men and it was in line with the Oman and Iraq studies \[[@CIT0006], [@CIT0008]\] as well as with the Iranian Survey in 2007 \[[@CIT0020]\] but it did not agree with the Tehran \[[@CIT0019]\], China \[[@CIT0026], [@CIT0027]\], Japan \[[@CIT0025]\], Korea \[[@CIT0007], [@CIT0024]\], and Asian Indian studies \[[@CIT0028]\] or with the values recommended by the IDF \[[@CIT0013]\], ATP III \[[@CIT0018], [@CIT0019]\], and WHO \[[@CIT0001]\] ([Table II](#T0002){ref-type="table"}). One possible explanation is that most Iranian women are housewives and they have a lesser role in social activities. But maybe the women in these countries work outside of their houses and these life habit changes and outdoor jobs are also seen nowadays in women who live in the capital city of Iran.

A comparison of the WC values between our females and those in other studies \[[@CIT0001], [@CIT0006], [@CIT0007], [@CIT0013], [@CIT0018], [@CIT0019], [@CIT0023]--[@CIT0028]\] demonstrates that only WC in Iraq is higher than that in our study \[[@CIT0008]\]. The WC values in the Hadaegh *et al*. study were higher than our values for detecting HTN and HC but lower for detecting DM. Their values, however, were approximately in line with ours \[[@CIT0022]\]. The values reported in the Iranian survey in 2007 \[[@CIT0020]\] for detecting HC were higher than our value but lower for detecting HTN and DM ([Table II](#T0002){ref-type="table"}).

A comparison of WC between men in our study and those in other studies in the existing literature shows that WC amongst our males was higher than that in the studies in Oman \[[@CIT0006]\], Korea \[[@CIT0024]\], Tunisia \[[@CIT0023]\], China \[[@CIT0027]\], and Asian Indians \[[@CIT0028]\] but lower than not only the values in the studies in Iraq \[[@CIT0008]\], Korea \[[@CIT0007]\], China \[[@CIT0026]\], Tehran \[[@CIT0019]\], and the Hadaegh *et al*. study \[[@CIT0022]\] but also the values recommended by the WHO, IDF, and ATP III \[[@CIT0001], [@CIT0013], [@CIT0018], [@CIT0019]\].

The WC in our study for detecting HTN was higher than the Japanese values, but it was lower for detecting DM and HC \[[@CIT0025]\]. Nonetheless, our values are more or less along the lines of the ones reported in Japan \[[@CIT0025]\], Korea \[[@CIT0007]\], and China \[[@CIT0026]\].

The WC values for detecting HTN and DM in our men were higher and for detecting HC were lower than the WC value for detecting the metabolic syndrome in the Iranian survey in 2007 \[[@CIT0020]\]. Still, our values are almost concordant with those in the said survey.

By comparing the variety of WC cut-off points obtained from different studies, it could be seen that the cut-off points for detecting chronic conditions such as DM, HTN and HC differ according to gender and ethnicity. Moreover, each of these conditions for detecting needs its own specific values.

Since the cut-off points of WC for detecting HC in both genders are less than the values for detecting DM and HTN, the recommended cut-off points of WC for preventing all three complications (DM, HTN and HC) in men and women are less than 88.2 cm and 90 cm respectively ([Table II](#T0002){ref-type="table"}).

In Tunisia, BMI for detecting CVD risk factors was 24 kg/m^2^ in men and 27 kg/m^2^ in women \[[@CIT0023]\]. In Oman, the optimal ranges of BMI in men and women (for detecting CVD) were 23.2 kg/m^2^ and 26.8 kg/m^2^, respectively \[[@CIT0006]\]. In these studies, like ours, the range of BMI in women was higher than that in men; but in Indian Asians, the normal cut-off point of BMI in both genders was 23 kg/m^2^ \[[@CIT0028]\] ([Table III](#T0003){ref-type="table"}).

###### 

Cut-off points of body mass index in different studies and their comparison with our results

  Study name \[reference\]                                                                                                      Body mass index \[kg/m^2^\]   
  ----------------------------------------------------------------------------------------------------------------------------- ----------------------------- ------------
  Our study (for detecting hypertension)                                                                                        25.7                          26.9
  Our study (for detecting diabetes)                                                                                            24.8                          26.3
  Our study (for detecting hypercholesterolemia)                                                                                24                            26.1
  World Health Organization (normal ranges in Asians) \[[@CIT0012]\][\*](#TF0001){ref-type="table-fn"}                          18.5 to 22                    18.5 to 22
  Asian study (for detecting obesity) \[[@CIT0029]\]                                                                            27                            25
  Iran (for detecting cardiovascular disease) \[[@CIT0022]\]                                                                    26.9                          29.1
  China (for detecting chronic disease risk factors by detecting overweight) \[[@CIT0027]\][\*](#TF0001){ref-type="table-fn"}   24                            24
  China (for detecting chronic disease risk factors by detecting obesity) \[[@CIT0027]\][\*](#TF0001){ref-type="table-fn"}      28                            28
  Oman (for detecting cardiovascular disease risk factors) \[[@CIT0006]\]                                                       23.2                          26.8
  Tunisia (for detecting cardiovascular disease) \[[@CIT0023]\]                                                                 24                            27
  Indian Asian (normal ranges) \[[@CIT0028]\]                                                                                   23                            23

The gender difference is not mentioned in the main article

In our study, the reference range of BMI for detecting HC in men was 24 kg/m^2^, which is in line with the range of BMI for detecting CVD in Tunisian men. Nevertheless, reference ranges for detecting HTN and DM in our study were higher than those in Tunisian men. On the other hand, in our women, the reference range of BMI for detecting HTN was approximately the same as the reference range of BMI for detecting CVD in Tunisian women, and the values in our study for detecting DM and HC were lower than theirs \[[@CIT0023]\].

In our study, the reference range of BMI in the men was higher than that in Oman and Indian Asian men \[[@CIT0006], [@CIT0028]\] and also it was higher than that recommended by the WHO \[[@CIT0012]\]. The reference range of BMI for detecting HTN in our women was approximately the same as that in the Oman study, but the ranges for detecting DM and HC were lower in our women than in the Oman women \[[@CIT0006]\] and were higher than the ranges in Indian Asians and values recommended by the WHO \[[@CIT0012], [@CIT0028]\] ([Table III](#T0003){ref-type="table"}).

Since the cut-off points of BMI for detecting HC in both genders are less than the values for detecting DM and HTN, the recommended cut-off points of BMI for preventing all three complications (DM, HTN and HC) in men and women are 24 kg/m^2^ and 26.1 kg/m^2^ respectively ([Table III](#T0003){ref-type="table"}).

In one Asian study, by reducing the BMI ranges for detecting obesity from 30 kg/m^2^ to 27 kg/m^2^ in men and 25 kg/m^2^ in women, sensitivity in men rose from 6.7% to 46.7% and sensitivity in women rose from 13.4% to 60.8% \[[@CIT0029]\]. In China, the reference range of BMI for defining overweight with best sensitivity and specificity for detecting chronic disease risk factors (hypertension, diabetes, dyslipidemia) was 24 kg/m^2^ and the cut-off point of BMI for defining obesity with 90% specificity was 28 kg/m^2^ \[[@CIT0027]\] ([Table III](#T0003){ref-type="table"}).

The South Asian population, the Chinese, and the aboriginal Canadians in comparison with Europeans are believed to have lower BMI but approximately the same lipid and glucose levels. Consequently, the cut-off point for the definition of obesity with respect to risk factors associated with glucose and lipid levels in Europeans is approximately 6 kg/m^2^ higher than in non-Europeans \[[@CIT0004]\].

Comparison of the cut-off points of BMI reported from different studies indicates that these values for detecting DM, HTN and WC differ according to gender and race. Moreover, each of these conditions for detection needs its own specific cut-off points.

In conclusion, this study was conducted according to the First Non-Communicable Disease Survey in Iran in 2005 and recruited a huge sample size. Our results show that the normal ranges of WC and BMI in Iranians were different from those of some other Asians as reported by the WHO \[[@CIT0012]\] or the IDF \[[@CIT0013]\]; approximately the same as the values of some Asian \[[@CIT0006], [@CIT0027]\] and African \[[@CIT0023]\] populations; and similar to the ranges in the Hadaegh *et al*. study in Iran \[[@CIT0022]\]. Our purpose in comparing the different cut-off points from different studies was to show the fact that these values vary according to gender and ethnicity. They are also different for detecting diabetes, hypertension and hypercholesterolemia.

The recommended cut-off points of BMI and WC for preventing all three complications (DM, HTN and HC) in men are 24 kg/m^2^ and 88.2 cm respectively and in women are 26.1 kg/m^2^ and 90 cm respectively. The WC range in our Iranian females was higher than that in our men, which agrees with the results from some other studies carried out in the Middle East \[[@CIT0006], [@CIT0008]\] and which may be due to the lesser role that women play in social activities in this part of the world. Another possible contributing factor is urbanization and the concomitant lifestyle changes and lower physical and social activities \[[@CIT0001], [@CIT0030]--[@CIT0032]\]. It is also worth noting that WC was higher in the Iranian women than in the women from some other Asian countries \[[@CIT0007], [@CIT0024]--[@CIT0028]\].

Given the higher BMI and WC in the women in our study and the direct link between obesity and CVD, DM, and dyslipidemia \[[@CIT0002], [@CIT0003]\], it is prudent that the causes of this phenomenon and their effect on women\'s health be fully investigated and the significance of losing weight and lifestyle modification be emphasized.

Some of the limitations of this study are the non-measurement of other lipid levels such as low-density lipoprotein (LDL), high-density lipoprotein (HDL) and triglycerides and also non-measurement of other metabolic syndrome criteria \[[@CIT0013]\], which were not measured in the national survey in 2005. The lipid profiles have been measured in the Iranian national survey in 2007 \[[@CIT0020], [@CIT0033]\]. On the other hand, our study was cross-sectional and was thus unable to follow the complications. It is, therefore, recommended that follow-up studies be conducted to determine the accurate cut-off points of anthropometric indices.
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